PL1622639T3 - Dożylne wstrzyknięcie nieneurotoksycznych aktywatorów plazminogenu do leczenia udaru mózgu - Google Patents
Dożylne wstrzyknięcie nieneurotoksycznych aktywatorów plazminogenu do leczenia udaru mózguInfo
- Publication number
- PL1622639T3 PL1622639T3 PL04730516T PL04730516T PL1622639T3 PL 1622639 T3 PL1622639 T3 PL 1622639T3 PL 04730516 T PL04730516 T PL 04730516T PL 04730516 T PL04730516 T PL 04730516T PL 1622639 T3 PL1622639 T3 PL 1622639T3
- Authority
- PL
- Poland
- Prior art keywords
- plasminogen
- intravenous injection
- treating cerebral
- cerebral stroke
- neurotoxic
- Prior art date
Links
- 102000013566 Plasminogen Human genes 0.000 title 1
- 108010051456 Plasminogen Proteins 0.000 title 1
- 208000006011 Stroke Diseases 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 238000010253 intravenous injection Methods 0.000 title 1
- 231100000501 nonneurotoxic Toxicity 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP03/04608 | 2003-05-02 | ||
| PCT/EP2003/004729 WO2004096267A1 (de) | 2003-05-02 | 2003-05-06 | Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall |
| PCT/EP2004/004626 WO2004096268A2 (de) | 2003-05-02 | 2004-04-30 | Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall |
| EP04730516A EP1622639B1 (de) | 2003-05-02 | 2004-04-30 | Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1622639T3 true PL1622639T3 (pl) | 2013-06-28 |
Family
ID=35610451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04730516T PL1622639T3 (pl) | 2003-05-02 | 2004-04-30 | Dożylne wstrzyknięcie nieneurotoksycznych aktywatorów plazminogenu do leczenia udaru mózgu |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1622639B1 (pl) |
| JP (1) | JP2006525270A (pl) |
| KR (1) | KR101212631B1 (pl) |
| BR (1) | BRPI0409865A (pl) |
| CA (1) | CA2524573A1 (pl) |
| HR (1) | HRP20050903B1 (pl) |
| NO (1) | NO337485B1 (pl) |
| NZ (1) | NZ543367A (pl) |
| PL (1) | PL1622639T3 (pl) |
| WO (1) | WO2004096268A2 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10153601A1 (de) | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| DE10342518A1 (de) * | 2003-09-12 | 2005-05-12 | Paion Gmbh | Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität |
| US8030350B2 (en) | 2005-02-24 | 2011-10-04 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
| EP1897554A1 (en) * | 2006-08-25 | 2008-03-12 | PAION Deutschland GmbH | Method for the manufacture of a medicament for treating hemorrhagic stroke |
| WO2008022801A1 (en) * | 2006-08-25 | 2008-02-28 | Paion Deutschland Gmbh | Method for the manufacture of a medicament for treating hemorrhagic stroke |
| MX2009010988A (es) | 2007-04-13 | 2010-03-15 | Diffusion Pharmaceuticals Llc | Uso de trans-carotenoides bipolares como un tratamiento previo y en el tratamiento de una enfermedad vascular periferica. |
| BRPI1010718A2 (pt) | 2009-06-10 | 2016-03-15 | Nono Inc | sistemas modelo e regimes de tratamento para tratar doença neurológica. |
| EP2445339B1 (en) | 2009-06-22 | 2019-08-07 | Diffusion Pharmaceuticals LLC | Diffusion enhancing compound and its use with a thrombolytic |
| US8652476B2 (en) | 2009-07-27 | 2014-02-18 | Niigata University | Pharmaceutical composition for treating ischemic events |
| JP5823671B2 (ja) * | 2009-07-27 | 2015-11-25 | 国立大学法人 新潟大学 | 免疫製剤を含む脳梗塞治療用医薬品組成物 |
| JP5823672B2 (ja) * | 2009-07-27 | 2015-11-25 | 国立大学法人 新潟大学 | 受容体シグナル伝達阻害剤を含む脳梗塞治療用医薬品組成物 |
| ES2654945T3 (es) | 2010-06-02 | 2018-02-15 | Diffusion Pharmaceuticals Llc | Formulaciones orales de carotenoides trans bipolares |
| KR102022116B1 (ko) | 2011-06-24 | 2019-09-18 | 노노 인코포레이티드 | 허혈에 대한 psd-95 억제제와의 조합 요법 |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| WO2017165667A1 (en) | 2016-03-24 | 2017-09-28 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
| US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI100403B (fi) * | 1988-07-20 | 1997-11-28 | Schering Ag | Menetelmä glykosyloitujen tai glykosyloimattomien vampyyrilepakon sylj en plasminogeeniaktivaattoreiden valmistamiseksi |
| NL8902454A (nl) * | 1989-10-03 | 1991-05-01 | Stichting Centraal Lab | Mutanten van de humane plasminogeen activator inhibitor 1 (pai-1), hun bereiding en toepassing, en recombinante polynucleotiden die voor deze mutanten coderende genetische informatie omvatten. |
| DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
-
2004
- 2004-04-30 PL PL04730516T patent/PL1622639T3/pl unknown
- 2004-04-30 HR HRP20050903AA patent/HRP20050903B1/hr not_active IP Right Cessation
- 2004-04-30 KR KR1020057020820A patent/KR101212631B1/ko not_active Expired - Fee Related
- 2004-04-30 JP JP2006505347A patent/JP2006525270A/ja not_active Withdrawn
- 2004-04-30 BR BRPI0409865-0A patent/BRPI0409865A/pt not_active IP Right Cessation
- 2004-04-30 EP EP04730516A patent/EP1622639B1/de not_active Expired - Lifetime
- 2004-04-30 NZ NZ543367A patent/NZ543367A/en not_active IP Right Cessation
- 2004-04-30 CA CA002524573A patent/CA2524573A1/en not_active Abandoned
- 2004-04-30 WO PCT/EP2004/004626 patent/WO2004096268A2/de not_active Ceased
-
2005
- 2005-12-01 NO NO20055692A patent/NO337485B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004096268A2 (de) | 2004-11-11 |
| KR101212631B1 (ko) | 2012-12-14 |
| EP1622639B1 (de) | 2013-01-16 |
| NO20055692D0 (no) | 2005-12-01 |
| JP2006525270A (ja) | 2006-11-09 |
| HRP20050903B1 (hr) | 2013-11-22 |
| NZ543367A (en) | 2010-06-25 |
| NO337485B1 (no) | 2016-04-25 |
| WO2004096268A3 (de) | 2005-04-21 |
| NO20055692L (no) | 2006-01-30 |
| HRP20050903A2 (en) | 2006-08-31 |
| BRPI0409865A (pt) | 2006-05-16 |
| KR20060020616A (ko) | 2006-03-06 |
| EP1622639A2 (de) | 2006-02-08 |
| CA2524573A1 (en) | 2004-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1622639T3 (pl) | Dożylne wstrzyknięcie nieneurotoksycznych aktywatorów plazminogenu do leczenia udaru mózgu | |
| IL173439A0 (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| EP1859914A4 (en) | METHOD FOR ADJUSTING THE CASTING CONDITIONS AND METHOD FOR CONTROLLING AN INJECTION MOLDING MACHINE | |
| PL372211A1 (pl) | Tiazolilomoczniki w leczeniu raka | |
| IL174951A0 (en) | Method for the production of amino crotonyl compounds | |
| IL183973A0 (en) | Spm 927 for add -on therapy of schizophrenia | |
| ZA200701583B (en) | Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 | |
| AU2003295537A8 (en) | Methods of treating cerebral ischemia | |
| EP1626692A4 (en) | COMPOUNDS FOR TREATING FLAVIVIRUS INFECTIONS | |
| IL175014A0 (en) | Method of administering therapeutic injections | |
| ZA200703704B (en) | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke | |
| AU2002350660A1 (en) | Non-neurotoxic plasminogen activating factors for treating stroke | |
| SI1697383T1 (sl) | Postopek za čiščenje takrolimusa | |
| AU2003296705A8 (en) | Method for controlling the production of injection molded parts | |
| AU2003213596A8 (en) | Intraspinal continuous infusion of midazolam hydrochloride for the treatment of pain | |
| HRP20030677A2 (en) | Methods of administering epothilone analogs for the treatment of cancer | |
| ZA200603153B (en) | Pyridine compounds as inhibitors of dipetidyl peptidase IV | |
| IL174369A0 (en) | Methods for treating bladder dysfunction | |
| GB2419843B (en) | Process control for gas-assisted injection molding applications | |
| IL156566A0 (en) | Urokinase plasminogen activator derived octapeptide in the treatment of multiple sclerosis | |
| TW569918U (en) | Auxiliary jig for forming mold of needle injecting type label piece | |
| GB2401573B (en) | Needle assembly for gas-assisted injection moulding | |
| PL1670841T3 (pl) | Sposób wytwarzania mieszanin polioli | |
| TW549219U (en) | Support sliding seat for fully injecting seat of injecting forming machine | |
| SI1519726T1 (sl) | Heteroarenski karboksamidi za uporabo kot ligandi dopamina D3 za zdravljenje bolezni CŽS |